Entero Therapeutics, Inc.
ENTO
$0.3541
-$0.0241-6.37%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -95.60% | -88.86% | -46.40% | 66.24% | 172.35% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -88.32% | -55.36% | -50.40% | 180.76% | -36.40% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1,584.33% | 2,008.39% | 3,485.13% | 112.19% | 45.22% |
|
|
|||||
| Total Current Assets | 1,584.33% | 2,008.39% | 3,485.13% | 112.19% | 45.22% |
| Net Property, Plant & Equipment | -39.62% | -38.21% | -36.56% | -26.08% | -30.72% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 1,089.79% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 1,089.79% | 0.00% |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 265.24% | 356.71% | 62.50% | 158,672.80% | -17.38% |
| Total Assets | 1,140.84% | 1,347.89% | 1,893.75% | 1,546.80% | 26.54% |
|
|
|||||
| Total Accounts Payable | 433.86% | 282.34% | 26.57% | 324.97% | -23.01% |
| Total Accrued Expenses | -69.47% | -73.73% | 279.77% | 202.05% | 157.75% |
| Short-term Debt | -- | -- | 15.70% | 1.68% | 1.54% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 21.46% | 21.75% | 21.70% | 4.86% | 1.36% |
| Total Finance Division Other Current Liabilities | 2,158.43% | 1,213.34% | 1,060.42% | 35.23% | 38.82% |
| Total Other Current Liabilities | 2,158.43% | 1,213.34% | 1,060.42% | 35.23% | 38.82% |
| Total Current Liabilities | 779.14% | 532.04% | 371.75% | 135.18% | 26.16% |
|
|
|||||
| Total Current Liabilities | 779.14% | 532.04% | 371.75% | 135.18% | 26.16% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | 15.70% | 1.68% | 1.54% |
| Capital Leases | -59.84% | -51.69% | -45.32% | -35.06% | -31.39% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 741.54% | 495.45% | 349.40% | 370.33% | 21.61% |
|
|
|||||
| Common Stock & APIC | 5.63% | 8.18% | 10.70% | 11.20% | 9.72% |
| Retained Earnings | -9.80% | -5.51% | -6.09% | -3.57% | -9.37% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -207.60% | 155.25% | 934.08% | 496.58% | 31.39% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -207.60% | 155.25% | 934.08% | 496.58% | 31.39% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1,504.39% | 2,036.46% | 7,927.40% | 2,770.45% | 31.39% |
|
|
|||||